SAFETY AND OUTCOME OF INTRAVENOUS THROMBOLYSIS WITH rtPA IN PATIENTS WITH ATRIAL FIBRILLATION

Background and purpose. Intravenous administration of recombinant tissue plasminogen activator (rtPA) is approved for the treatment of patients with acute ischemic stroke. It is still controversial if in patients with ischemic stroke due to atrial fibrillation this treatment has the same efficacy as...

Full description

Bibliographic Details
Main Authors: Elena Terecoasa, Cristina Tiu, Marta Guillan, Victor Sanchez-Gonzalez, Maria Alonso de Lecinana, Jaime Masjuan
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2012-09-01
Series:Romanian Journal of Neurology
Subjects:
Online Access:https://revistemedicale.amaltea.ro/Romanian_Journal_of_NEUROLOGY/Revista_Romana_de_NEUROLOGIE-2012-Nr.3/RJN_2012_3_Art-03.pdf